Tag Archives: Clinical Outcome Assessment Compendium

FASEB questions utility of FDA pilot program

In response to a request from the Food and Drug Administration (FDA), the Federation of American Societies for Experimental Biology (FASEB) submitted comments questioning the usefulness of the pilot Clinical Outcome Assessment Compendium (COAC) on March 2. Intended to provide clarity to researchers designing clinical trials or developing new drugs, the COAC combines metrics for… Read More »